Insiders Arvinas, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 13:37:32 2024-05-21 EDT			5-day change	1st Jan Change
34.18 ^USD	+2.77%		+8.16%	-17.59%

05-16	Sector Update: Health Care Stocks Steady Premarket Thursday	MT
05-16	Sector Update: Health Care	MT

Arvinas, Inc. Appoints Randy Teel as Chief Business Officer	04-24	CI
Arvinas Appoints Noah Berkowitz as Chief Medical Officer	03-18	MT
Arvinas, Inc. Appoints Noah Berkowitz as Chief Medical Officer and A Member of the Executive Committee	03-18	CI
Arvinas, Inc. Announces Executive Changes, Effective February 29, 2024	02-20	CI
Arvinas, Inc. Announces Appointment of Jared Freedberg as General Counsel	01-16	CI
Arvinas Names John Houston Chairperson, Effective Thursday	23-06-15	MT
Arvinas, Inc. Announces Changes to its Board of Directors	23-06-15	CI
Arvinas, Inc. Appoints Kelly Page as Senior Vice President, Global Head of Oncology Strategy and Program Leadership	23-04-03	CI
Arvinas, Inc. Announces Executive Changes	22-12-16	CI
Arvinas Announces Changes to Its Board of Directors	22-12-16	CI
Brand Institute Partners on Nonproprietary Name for Novel Protein Degrader Under Development by Arvinas, Inc	22-12-05	CI
Arvinas, Inc. Appoints Paul McInulty as Senior Vice President, Regulatory Affairs	22-10-03	CI
Arvinas, Inc. Announces Changes to its Board of Directors	22-08-18	CI
Arvinas, Inc. Appoints Lisa Sinclair as Senior Vice President, Corporate Operations	22-08-15	CI
Arvinas, Inc. Appoints John Northcott as Chief Commercial Officer	22-08-01	CI
Insider Sell: Arvinas	22-04-19	MT
Insider Sell: Arvinas	22-03-16	MT
Insider Sell: Arvinas	22-02-18	MT
Insider Sell: Arvinas	22-01-20	MT
Insider Sell: Arvinas	21-12-17	MT

No results for this search